2019 ASH-AMFDP Hematology Scholar to Study the Biology of T-Cell Lymphoma
Published on: February 19, 2019
(WASHINGTON, February 19, 2019) — The American Society
of Hematology (ASH) is pleased to announce that Carlos Murga-Zamalloa, MD, of the
University of Michigan Health System has been selected to participate in the
American Society of Hematology-Harold Amos Medical Faculty Development Program
(ASH-AMFDP), a partnership between ASH and the Robert Wood Johnson Foundation.
Designed to increase the number of underrepresented
minority scholars in the field of hematology with academic and research
appointments, the ASH-AMFDP provides four-year research awards, totaling
$420,000 over the course of the program. Dr. Murga-Zamalloa will spend at least
70 percent of his ASH-AMFDP-funded research under the mentorship of a senior
faculty member at his institution.
Dr. Murga-Zamalloa’s research focuses on the biology
of T-cell lymphoma, with an emphasis on the role of actin-related
signaling during T-cell lymphoma progression. He hopes that his project will result
in the discovery of novel signaling pathways that contribute to the progression
of T-cell lymphomas, and that this knowledge will lead to future therapeutic
approaches. Dr. Murga-Zamalloa currently serves as a house officer of the
department of pathology at the University of Michigan Health
System in Ann Arbor, Michigan.
“ASH is pleased to support Dr. Murga-Zamalloa and provide
him with the resources he needs to reach his career goals in academic research,”
said 2019 ASH President Roy Silverstein, MD, of the Medical College of
Wisconsin in Milwaukee. “Thanks to our partnership with the Robert Wood Johnson
Foundation, ASH is able to support talented scholars from diverse backgrounds whose varied experiences and perspectives help to
enrich the field of hematology.”
The ASH-AMFDP program is a component of the ASH
Minority Recruitment Initiative, which is dedicated to encouraging diversity
in the field of hematology.
Society of Hematology (ASH) (www.hematology.org) is the
world’s largest professional society of hematologists dedicated to furthering
the understanding, diagnosis, treatment, and prevention of disorders affecting
the blood. For 60 years, the Society has led the development of hematology as a
discipline by promoting research, patient care, education, training, and
advocacy in hematology. ASH publishes Blood (www.bloodjournal.org),
the most cited peer-reviewed publication in the field, which is available
weekly in print and online, as well as the newly launched, online,
peer-reviewed open-access journal, Blood Advances (www.bloodadvances.org).
back to top
Sara Khalaf, American Society of Hematology